Except for women in their 40s, women who are screened with mammography every 2 years may not have an increased risk of late-stage breast cancer compared with women screened every year, according to a new study in the December 15 issue of the Journal of the National Cancer Institute.
The ideal interval between screenings for breast cancer using mammography has not been determined. In the United States, the U.S. Preventive Services Task Force recommends screening with mammography every 1 to 2 years, whereas the American Cancer Society recommends annual screening. In Europe, most countries recommend that women be screened every 2 years and concentrate their recommendations on women age 50 and older.
To determine if women screened every 2 years have an increased risk of late-stage breast cancer, Emily White, Ph.D., of the Fred Hutchinson Cancer Research Center in Seattle, and colleagues conducted an observational study using data collected by seven mammography registries in the United States. They examined whether the 2,440 women who had been diagnosed with breast cancer after receiving biennial screening were more likely to have been diagnosed with late-stage cancer compared with 5,400 women diagnosed with breast cancer after receiving annual screening.
Sarah L. Zielinski | EurekAlert!
Some brain tumors may respond to immunotherapy, new study suggests
11.12.2018 | Columbia University Irving Medical Center
Climate change and air pollution damaging health and causing millions of premature deaths
30.11.2018 | International Institute for Applied Systems Analysis (IIASA)
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
13.12.2018 | Life Sciences
13.12.2018 | Physics and Astronomy
13.12.2018 | Earth Sciences